D'Haese PC - Search Results

1

Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?

Viaene L, Behets GJ, Claes K, Meijers B, Blocki F, Brandenburg V, Evenepoel P, D'Haese PC. Viaene L, et al. Nephrol Dial Transplant. 2013 Dec;28(12):3024-30. doi: 10.1093/ndt/gft039. Epub 2013 Apr 19. Nephrol Dial Transplant. 2013. PMID: 23605174

2

Pharmacokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients.

Verpooten GA, D'Haese PC, Boelaert JR, Becaus I, Lamberts LV, De Broe ME. Verpooten GA, et al. Nephrol Dial Transplant. 1992;7(9):931-8. doi: 10.1093/ndt/7.9.931. Nephrol Dial Transplant. 1992. PMID: 1328941 Clinical Trial.

3

Value of serum aluminium monitoring in dialysis patients: a multicentre study.

D'Haese PC, Clement JP, Elseviers MM, Lamberts LV, Van de Vyver FL, Visser WJ, De Broe ME. D'Haese PC, et al. Nephrol Dial Transplant. 1990;5(1):45-53. doi: 10.1093/ndt/5.1.45. Nephrol Dial Transplant. 1990. PMID: 2109284 Clinical Trial.

4

Iron overload and bone disease in chronic dialysis patients.

Van de Vyver FL, Visser WJ, D'Haese PC, De Broe ME. Van de Vyver FL, et al. Nephrol Dial Transplant. 1990;5(9):781-7. doi: 10.1093/ndt/5.9.781. Nephrol Dial Transplant. 1990. PMID: 2129351

5

Risk of aluminium intoxication in long-term acetate Redy dialysis.

Van de Vyver FL, Visser WJ, D'Haese PC, Silva FJ, Thomas H, De Broe ME. Van de Vyver FL, et al. Nephrol Dial Transplant. 1989;4(6):555-62. Nephrol Dial Transplant. 1989. PMID: 2507978

6

Aluminum accumulation in children on chronic dialysis: predictive value of serum aluminum levels and desferrioxamine infusion test.

Roodhooft AM, van de Vyver FL, D'Haese PC, van Acker KJ, Visser WJ, de Broe ME. Roodhooft AM, et al. Clin Nephrol. 1987 Sep;28(3):125-9. Clin Nephrol. 1987. PMID: 3665205

7

New insights and strategies in the diagnosis and treatment of aluminium overload in dialysis patients.

De Broe ME, D'Haese PC, Couttenye MM, Van Landeghem GF, Lamberts LV. De Broe ME, et al. Nephrol Dial Transplant. 1993;8 Suppl 1:47-50. doi: 10.1093/ndt/8.supp1.47. Nephrol Dial Transplant. 1993. PMID: 8389021 No abstract available.

8

Increased silicon levels in dialysis patients due to high silicon content in the drinking water, inadequate water treatment procedures, and concentrate contamination: a multicentre study.

D'Haese PC, Shaheen FA, Huraib SO, Djukanovic L, Polenakovic MH, Spasovski G, Shikole A, Schurgers ML, Daneels RF, Lamberts LV, et al. D'Haese PC, et al. Nephrol Dial Transplant. 1995 Oct;10(10):1838-44. Nephrol Dial Transplant. 1995. PMID: 8592591

9

Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminium-related bone disease, increased risk for aluminium toxicity, or aluminium overload.

D'Haese PC, Couttenye MM, Goodman WG, Lemoniatou E, Digenis P, Sotornik I, Fagalde A, Barsoum RS, Lamberts LV, De Broe ME. D'Haese PC, et al. Nephrol Dial Transplant. 1995 Oct;10(10):1874-84. Nephrol Dial Transplant. 1995. PMID: 8592597 Clinical Trial.

10

Low-dose (5 mg/kg) desferrioxamine treatment in acutely aluminium-intoxicated haemodialysis patients using two drug administration schedules.

Barata JD, D'Haese PC, Pires C, Lamberts LV, Simões J, De Broe ME. Barata JD, et al. Nephrol Dial Transplant. 1996 Jan;11(1):125-32. Nephrol Dial Transplant. 1996. PMID: 8649620 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters